Search research articles
Contact Us
Filters
Showing results (361-370 of 497) with videos related to
Page
of 50
Sort By:
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism
Alexander Solms, Stefan Willmann, Isabel Reinecke, et al.
Journal of Community Psychology
|
May 6, 2023
School partner perspectives on the implementation of the Your Voice Your View sexual assault prevention program for high school students
Lindsay M Orchowski, Claudia Paszek, Richard M Lopez, et al.
International Journal of Cardiology
|
May 6, 2021
Risk stratification of cardiovascular complications using CHA<sub>2</sub>DS<sub>2</sub>-VASc and CHADS<sub>2</sub> scores in chronic atherosclerotic cardiovascular disease
Jonathan Sen, Andrew Tonkin, John Varigos, et al.
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism
Isabel Reinecke, Alexander Solms, Stefan Willmann, et al.
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation
Liping Zhang, Xiaoyu Yan, Keith A A Fox, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 3, 2003
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
C W Colwell, S D Berkowitz, B L Davidson, et al.
Stroke
|
July 10, 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source
Jan F Scheitz, Guillaume Pare, Lesly A Pearce, et al.
Therapeutic Advances in Cardiovascular Disease
|
August 1, 2019
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome
Liping Zhang, Xiaoyu Yan, Partha Nandy, et al.
Circulation
|
February 20, 2024
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, et al.
Annals of Internal Medicine
|
October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial
Charles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
Page
of 50
Search research articles
Search
Showing results (361-370 of 497) with videos related to
Sort By:
Page
of 50
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism
Alexander Solms, Stefan Willmann, Isabel Reinecke, et al.
Journal of Community Psychology
|
May 6, 2023
School partner perspectives on the implementation of the Your Voice Your View sexual assault prevention program for high school students
Lindsay M Orchowski, Claudia Paszek, Richard M Lopez, et al.
International Journal of Cardiology
|
May 6, 2021
Risk stratification of cardiovascular complications using CHA<sub>2</sub>DS<sub>2</sub>-VASc and CHADS<sub>2</sub> scores in chronic atherosclerotic cardiovascular disease
Jonathan Sen, Andrew Tonkin, John Varigos, et al.
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism
Isabel Reinecke, Alexander Solms, Stefan Willmann, et al.
Journal of Thrombosis and Thrombolysis
|
April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation
Liping Zhang, Xiaoyu Yan, Keith A A Fox, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 3, 2003
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
C W Colwell, S D Berkowitz, B L Davidson, et al.
Stroke
|
July 10, 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source
Jan F Scheitz, Guillaume Pare, Lesly A Pearce, et al.
Therapeutic Advances in Cardiovascular Disease
|
August 1, 2019
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome
Liping Zhang, Xiaoyu Yan, Partha Nandy, et al.
Circulation
|
February 20, 2024
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD
Shea E Hogan, Eike Sebastian Debus, Mark R Nehler, et al.
Annals of Internal Medicine
|
October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial
Charles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
Page
of 50